ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,630.05
0.22%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.2625
0.01%
Brent Oil
81.295
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. ANI Pharmaceuticals Inc (ANIP)

  7. ANI Pharmaceuticals Inc (ANIP) ニュース

ANIP

ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ANIP
日付受信時刻ニュースソース見出しコード企業名
2024/05/3005 : 30GlobeNewswire Inc.ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2409 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2409 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2408 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2408 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2408 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2405 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2307 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2206 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2105 : 57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/2019 : 50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Kionex® SuspensionNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1807 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1807 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1805 : 50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1706 : 02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1706 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1705 : 49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1605 : 59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1508 : 47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1505 : 11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1406 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1020 : 09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1019 : 55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/1019 : 50GlobeNewswire Inc.ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 GuidanceNASDAQ:ANIPANI Pharmaceuticals Inc
2024/05/0205 : 30GlobeNewswire Inc.ANI Pharmaceuticals to Participate at Two Upcoming Healthcare ConferencesNASDAQ:ANIPANI Pharmaceuticals Inc
2024/04/1905 : 05GlobeNewswire Inc.ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ETNASDAQ:ANIPANI Pharmaceuticals Inc
2024/04/0919 : 50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Baclofen Oral SuspensionNASDAQ:ANIPANI Pharmaceuticals Inc
2024/04/0419 : 50GlobeNewswire Inc.ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with SarcoidosisNASDAQ:ANIPANI Pharmaceuticals Inc
2024/04/0319 : 50GlobeNewswire Inc.ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma SymposiumNASDAQ:ANIPANI Pharmaceuticals Inc
2024/03/2719 : 50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USPNASDAQ:ANIPANI Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ANIP

最近閲覧した銘柄

NASDAQ
CTCX
Carmell
USOTC
SGPYY
Sage (PK)
LSE
78LV
Silverstone 55
LSE
VKW
KOSPI
550070
Qv Inverse 2x Copper Fut...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有